# National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Player with a 1.59% Dividend Yield

- Link: https://www.directorstalkinterviews.com/national-healthcare-corporation-nhc-stock-analysis-a-stable-healthcare-player-with-a-1-59-dividend-yield/4121243852
- Published: 2026-03-10T11:31:02+00:00
- Author: Madison Wilson

National HealthCare Corporation (NHC), a stalwart in the healthcare sector, offers
investors a robust business model centered around medical care facilities. With 
a market capitalization of $2.49 billion, NHC stands as a significant player in 
the U.S. healthcare landscape, offering skilled nursing, assisted living, homecare,
and hospice services. This article delves into NHC’s financial health, performance
metrics, and growth prospects, providing insights for investors considering this
stock for their portfolios.

#### Price and Valuation Metrics

NHC’s current stock price is $160.52, reflecting a slight price change of -0.04%
recently. The 52-week range of $89.91 to $172.83 highlights the stock’s considerable
upward trajectory over the past year. Despite this growth, traditional valuation
metrics such as the P/E ratio, PEG ratio, and EV/EBITDA are not available for NHC,
which poses a challenge for investors relying on these indicators for valuation.
However, the absence of these metrics may suggest unique accounting practices or
financial strategies specific to the company.

#### Performance Metrics

The company reports a revenue growth rate of 4.60%, which may not be stellar but
indicates steady progress in an industry characterized by stability over rapid expansion.
An EPS of 7.67 and a return on equity of 11.92% underscore the company’s profitability
and efficient use of shareholder equity. Furthermore, with a free cash flow of over
$108 million, NHC demonstrates strong cash generation capabilities, an essential
factor in sustaining operations and funding potential expansions or acquisitions.

#### Dividend Insights

For income-focused investors, NHC offers a dividend yield of 1.59%, supported by
a conservative payout ratio of 32.99%. This suggests that the company retains a 
significant portion of its earnings, potentially reinvesting in business growth 
or maintaining financial flexibility. The dividend yield, while modest, offers a
stable income stream, appealing to investors seeking reliability in their returns.

#### Technical Indicators and Market Sentiment

From a technical perspective, NHC’s stock is performing above its 50-day and 200-
day moving averages, which are $149.84 and $124.01, respectively. This technical
strength may signal bullish sentiment among traders. However, with an RSI of 48.34,
the stock is neither overbought nor oversold, indicating a period of consolidation.
The MACD at 4.56, slightly below the signal line of 5.21, suggests a cautious approach
might be prudent until clearer momentum trends emerge.

#### Analyst Ratings and Market Outlook

Interestingly, there are no current buy, hold, or sell ratings for NHC, nor are 
there available target price ranges. This lack of analyst coverage might present
an opportunity for investors to conduct their own research and form independent 
valuations of the company. The absence of mainstream attention could mean that the
stock is undervalued or overlooked, offering potential upside for those willing 
to delve deeper into its fundamentals.

#### Conclusion

National HealthCare Corporation presents a compelling case for investors focused
on the healthcare sector. While lacking in certain traditional valuation metrics
and analyst coverage, the company shows strong profitability, steady revenue growth,
and offers a reliable dividend yield. Its comprehensive range of services across
skilled nursing, assisted living, and homecare provides a stable revenue base in
a sector with consistent demand. Investors with a long-term horizon and a focus 
on dividend income might find NHC an attractive addition to their portfolios, particularly
if they value stability and potential growth in the healthcare industry.

Share on:
